Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.
Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Anagnostis P, et al. J Clin Endocrinol Metab. 2009 Aug;94(8):2692-701. doi: 10.1210/jc.2009-0370. Epub 2009 May 26. J Clin Endocrinol Metab. 2009. PMID: 19470627 Review.
Metabolic syndrome in the Mediterranean region: Current status.
Anagnostis P. Anagnostis P. Indian J Endocrinol Metab. 2012 Jan;16(1):72-80. doi: 10.4103/2230-8210.91195. Indian J Endocrinol Metab. 2012. PMID: 22276255 Free PMC article.
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M, Mikhailidis DP. Anagnostis P, et al. Metabolism. 2013 Jan;62(1):21-33. doi: 10.1016/j.metabol.2012.05.002. Epub 2012 May 30. Metabolism. 2013. PMID: 22652056 Review.
Psoriasis and Vascular Risk : An Update.
Katsiki N, Anagnostis P, Athyros VG, Karagiannis A, Mikhailidis DP. Katsiki N, et al. Curr Pharm Des. 2014;20(39):6114-25. doi: 10.2174/1381612820666140417105323. Curr Pharm Des. 2014. PMID: 24745923 Review.
Subclinical Cushing's syndrome and cardiovascular disease.
Anagnostis P, Karras SN, Athyros VG, Mikhailidis DP, Karagiannis A. Anagnostis P, et al. Lancet Diabetes Endocrinol. 2014 May;2(5):361. doi: 10.1016/S2213-8587(14)70080-4. Lancet Diabetes Endocrinol. 2014. PMID: 24795246 No abstract available.
Effects of gender, age and menopausal status on serum apolipoprotein concentrations.
Anagnostis P, Stevenson JC, Crook D, Johnston DG, Godsland IF. Anagnostis P, et al. Clin Endocrinol (Oxf). 2016 Nov;85(5):733-740. doi: 10.1111/cen.13085. Epub 2016 Apr 29. Clin Endocrinol (Oxf). 2016. PMID: 27086565

ApoA-I concentrations were highest in postmenopausal women and lowest in men (standardized median (IQR) 144 (130, 158) vs 119 (108, 132) g/l, respectively, P < 0·001). ApoA-II concentrations were also highest in postmenopausal women but were lowest in premenopausal wome

ApoA-I concentrations were highest in postmenopausal women and lowest in men (standardized median (IQR) 144 (130, 158) vs 119 (108, 132) g/l …
Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Katsiki N, Perez-Martinez P, Anagnostis P, Mikhailidis DP, Karagiannis A. Katsiki N, et al. Curr Vasc Pharmacol. 2018;16(3):219-227. doi: 10.2174/1570161115666170621075619. Curr Vasc Pharmacol. 2018. PMID: 28669328 Review.
Letter to the Editor: Genetics and Vitamin D Supplementation in Pregnancy.
Paschou SA, Anagnostis PG, Muscogiuri G, Goulis DG, Vryonidou A. Paschou SA, et al. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3563-3564. doi: 10.1210/jc.2017-01318. J Clin Endocrinol Metab. 2017. PMID: 28911161 No abstract available.
Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management.
Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Paschou SA, et al. J Clin Endocrinol Metab. 2017 Oct 1;102(10):3621-3634. doi: 10.1210/jc.2017-00042. J Clin Endocrinol Metab. 2017. PMID: 28938433 Review.
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.
Anagnostis P, Tarlatzis BC, Kauffman RP. Anagnostis P, et al. Metabolism. 2018 Sep;86:33-43. doi: 10.1016/j.metabol.2017.09.016. Epub 2017 Oct 10. Metabolism. 2018. PMID: 29024702 Review.
194 results
Jump to page